SG11202005974YA - Use of inhaled nitric oxide and oxygen for the treatment of pulmonary hypertension - Google Patents

Use of inhaled nitric oxide and oxygen for the treatment of pulmonary hypertension

Info

Publication number
SG11202005974YA
SG11202005974YA SG11202005974YA SG11202005974YA SG11202005974YA SG 11202005974Y A SG11202005974Y A SG 11202005974YA SG 11202005974Y A SG11202005974Y A SG 11202005974YA SG 11202005974Y A SG11202005974Y A SG 11202005974YA SG 11202005974Y A SG11202005974Y A SG 11202005974YA
Authority
SG
Singapore
Prior art keywords
oxygen
treatment
nitric oxide
pulmonary hypertension
inhaled nitric
Prior art date
Application number
SG11202005974YA
Other languages
English (en)
Inventor
Deborah Quinn
Parag Shah
Original Assignee
Bellerophon Pulse Tech Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bellerophon Pulse Tech Llc filed Critical Bellerophon Pulse Tech Llc
Publication of SG11202005974YA publication Critical patent/SG11202005974YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/12—Preparation of respiratory gases or vapours by mixing different gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/06—Respiratory or anaesthetic masks
    • A61M16/0666—Nasal cannulas or tubing
    • A61M16/0672—Nasal cannula assemblies for oxygen therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/1005—Preparation of respiratory gases or vapours with O2 features or with parameter measurement
    • A61M16/101—Preparation of respiratory gases or vapours with O2 features or with parameter measurement using an oxygen concentrator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/0007—Special media to be introduced, removed or treated introduced into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0208—Oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0266—Nitrogen (N)
    • A61M2202/0275—Nitric oxide [NO]

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11202005974YA 2017-12-28 2018-12-28 Use of inhaled nitric oxide and oxygen for the treatment of pulmonary hypertension SG11202005974YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762611316P 2017-12-28 2017-12-28
PCT/US2018/067793 WO2019133776A1 (en) 2017-12-28 2018-12-28 Use of inhaled nitric oxide and oxygen for the treatment of pulmonary hypertension

Publications (1)

Publication Number Publication Date
SG11202005974YA true SG11202005974YA (en) 2020-07-29

Family

ID=67068194

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202005974YA SG11202005974YA (en) 2017-12-28 2018-12-28 Use of inhaled nitric oxide and oxygen for the treatment of pulmonary hypertension

Country Status (15)

Country Link
US (1) US20200360425A1 (ko)
EP (1) EP3731913A4 (ko)
JP (1) JP2021509108A (ko)
KR (1) KR20200127157A (ko)
CN (1) CN111867664A (ko)
AU (1) AU2018394928A1 (ko)
BR (1) BR112020012964A2 (ko)
CA (1) CA3087195A1 (ko)
EA (1) EA202091286A1 (ko)
IL (1) IL275678A (ko)
MX (1) MX2020006741A (ko)
PH (1) PH12020550978A1 (ko)
SG (1) SG11202005974YA (ko)
TW (1) TW201929841A (ko)
WO (1) WO2019133776A1 (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020010523A (es) 2017-02-27 2021-02-09 Third Pole Inc Sistemas y metodos para generar oxido nitrico.
CN110573454B (zh) 2017-02-27 2021-08-20 第三极股份有限公司 生成一氧化氮的系统和方法
JP2020510499A (ja) 2017-02-27 2020-04-09 サード ポール, インコーポレイテッドThird Pole, Inc. 酸化窒素の移動式生成システムおよび方法
TW202021637A (zh) * 2018-08-10 2020-06-16 美商貝勒羅豐治療公司 吸入性一氧化氮（ｉＮＯ）用於改善嚴重低血氧症之用途
US11045620B2 (en) 2019-05-15 2021-06-29 Third Pole, Inc. Electrodes for nitric oxide generation
EP3969416A4 (en) 2019-05-15 2023-11-01 Third Pole, Inc. SYSTEMS AND METHODS FOR GENERATING NITRIC OXIDE
US11691879B2 (en) 2020-01-11 2023-07-04 Third Pole, Inc. Systems and methods for nitric oxide generation with humidity control
WO2021243227A1 (en) * 2020-05-29 2021-12-02 Bellerophon Therapeutics Method for pulsatile delivery of a gaseous drug
EP4167920A1 (en) 2020-06-18 2023-04-26 Third Pole, Inc. Systems and methods for preventing and treating infections with nitric oxide
US11975139B2 (en) 2021-09-23 2024-05-07 Third Pole, Inc. Systems and methods for delivering nitric oxide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2544724T3 (es) * 2006-12-12 2015-09-03 Gilead Sciences, Inc. Composición para tratar una hipertensión pulmonar
CN106572813B (zh) * 2014-03-28 2020-07-17 沙普医疗系统公司 用于量化慢性疾病的多种可能形式对被报告呼吸困难的患者的贡献的可能性的模式识别系统
US20170165447A1 (en) * 2015-12-11 2017-06-15 Geno Llc Method and apparatus for administering gases including nitric oxide
US20170182088A1 (en) * 2015-12-28 2017-06-29 Geno Llc Method and apparatus for administering nitric oxide with supplemental drugs
JP2019513691A (ja) * 2016-02-12 2019-05-30 マリンクロット ホスピタル プロダクツ アイピー リミテッド 吸入用一酸化窒素の左心補助人工心臓への使用とモニタリング

Also Published As

Publication number Publication date
AU2018394928A1 (en) 2020-07-02
EA202091286A1 (ru) 2020-11-05
EP3731913A1 (en) 2020-11-04
EP3731913A4 (en) 2021-09-01
JP2021509108A (ja) 2021-03-18
BR112020012964A2 (pt) 2020-12-01
CN111867664A (zh) 2020-10-30
IL275678A (en) 2020-08-31
CA3087195A1 (en) 2019-07-04
US20200360425A1 (en) 2020-11-19
KR20200127157A (ko) 2020-11-10
MX2020006741A (es) 2020-11-24
PH12020550978A1 (en) 2021-04-19
TW201929841A (zh) 2019-08-01
WO2019133776A1 (en) 2019-07-04

Similar Documents

Publication Publication Date Title
IL275678A (en) Using nitrous oxide and inhaled oxygen to treat pulmonary hypertension
IL275683A (en) Administering pulses of inhaled nitrous oxide for the treatment of pulmonary hypertension
IL272314A (en) Use of inhaled nitrous oxide to treat pulmonary hypertension associated with lung disease
IL291718A (en) Single-use oxygen reduction kits, devices and methods for their use
EP3413899A4 (en) USE AND MONITORING OF INHALED STAIN OXIDE WITH LEFT-VENTRICULAR SUPPORT DEVICES
GB2599818B (en) Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
IL271117B (en) Diazabicyclic mutated imidazopyrimidines and their use in the treatment of respiratory disorders
IL261932A (en) Use of probiotics in the treatment and/or prevention of eczema
RS62632B1 (sr) Dalargin za upotrebu u lečenju akutnih respiratornih virusnih infekcija
IL281445A (en) Therapeutic nanoparticles and methods for their use
IL265881A (en) Inhaler and methods of use thereof
IL290754A (en) Use of pyridofidine to treat anxiety and depression
PT3307293T (pt) Formulações para o tratamento de distúrbios da boca, garganta e trato respiratório
EP3116363A4 (en) Nitrous oxide mixtures and methods of use
HK1257588A1 (zh) 預防和治療肺纖維化的藥物及其用途
EP3541185A4 (en) USE OF 2-HYDROXYBENZYLAMINE IN THE TREATMENT AND PREVENTION OF PULMONARY HYPERTENSION
EP3703660A4 (en) NITRIC OXIDE INHALATION
EP3723742C0 (fr) Utilisation de la fluoroethylnormemantine pour la prevention et le traitement de l'anxiete
IL276792A (en) Inhaler and methods for using it
HK1258614A1 (zh) 一氧化二氮混合物及使用方法
EP3648789C0 (en) MTMR2-S POLYPEPTIDE FOR USE IN THE TREATMENT OF MYOPATHY
SG11201802955VA (en) Peptides of use in the preventive and curative treatment of alopecia
GB201521442D0 (en) Polytpeptides and analogues thereof for use in the treatment of diabetes and bone disorders
GB201915277D0 (en) Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
GB201907971D0 (en) Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract